Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP614328.RA0rQ1ajI1tOOdNw1n34iUd2gDw-innQy7dGG5D6rbyCo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP614328.RA0rQ1ajI1tOOdNw1n34iUd2gDw-innQy7dGG5D6rbyCo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP614328.RA0rQ1ajI1tOOdNw1n34iUd2gDw-innQy7dGG5D6rbyCo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP614328.RA0rQ1ajI1tOOdNw1n34iUd2gDw-innQy7dGG5D6rbyCo130_provenance.
- NP614328.RA0rQ1ajI1tOOdNw1n34iUd2gDw-innQy7dGG5D6rbyCo130_assertion description "[Inhibitors of the tyrosine kinase receptors, such as IGF-1R, c-kit, PDGFR, VEGFR, or the mTOR signaling pathway, proteasome, angiogenesis, and stress response proteins are under clinical evaluation against sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614328.RA0rQ1ajI1tOOdNw1n34iUd2gDw-innQy7dGG5D6rbyCo130_provenance.
- NP614328.RA0rQ1ajI1tOOdNw1n34iUd2gDw-innQy7dGG5D6rbyCo130_assertion evidence source_evidence_literature NP614328.RA0rQ1ajI1tOOdNw1n34iUd2gDw-innQy7dGG5D6rbyCo130_provenance.
- NP614328.RA0rQ1ajI1tOOdNw1n34iUd2gDw-innQy7dGG5D6rbyCo130_assertion SIO_000772 19013896 NP614328.RA0rQ1ajI1tOOdNw1n34iUd2gDw-innQy7dGG5D6rbyCo130_provenance.
- NP614328.RA0rQ1ajI1tOOdNw1n34iUd2gDw-innQy7dGG5D6rbyCo130_assertion wasDerivedFrom befree-20150227 NP614328.RA0rQ1ajI1tOOdNw1n34iUd2gDw-innQy7dGG5D6rbyCo130_provenance.
- NP614328.RA0rQ1ajI1tOOdNw1n34iUd2gDw-innQy7dGG5D6rbyCo130_assertion wasGeneratedBy ECO_0000203 NP614328.RA0rQ1ajI1tOOdNw1n34iUd2gDw-innQy7dGG5D6rbyCo130_provenance.
- befree-20150227 importedOn "2015-02-27" NP614328.RA0rQ1ajI1tOOdNw1n34iUd2gDw-innQy7dGG5D6rbyCo130_provenance.